Published online Aug 19, 2026. doi: 10.5498/wjp.v16.i8.118042
Revised: March 7, 2026
Accepted: May 18, 2026
Published online: August 19, 2026
Processing time: 220 Days and 6.1 Hours
Sleep disturbance is one of the most common and clinically important features of depressive disorders. Although it has traditionally been viewed as a secondary symptom of depression, growing evidence indicates that sleep disturbance plays an active role in both the development and persistence of depressive illness. Lon
Core Tip: Sleep disturbance and depression interact in a bidirectional and self-reinforcing manner rather than a simple cause-effect relationship. Accumulating evidence shows that insomnia, poor sleep quality, and circadian rhythm disruption not only result from depression but also actively contribute to its onset, persistence, and relapse through shared neurobiological, emotional, and behavioral mechanisms. Recognizing sleep disturbance as a core and modifiable component of depressive disorders supports routine sleep assessment and the integration of targeted sleep interventions, such as cognitive behavioral therapy for insomnia, into standard depression care to improve outcomes and reduce relapse risk.
- Citation: Sanan M, Yao S, Wareesawetsuwan N, Zhang PF, Song XQ. Bidirectional relationship between sleep disturbance and depression: Mechanisms, clinical implications, and future directions. World J Psychiatry 2026; 16(8): 118042
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/118042.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i8.118042
Depressive disorders represent a major global public health challenge, contributing substantially to disability, reduced quality of life, and premature mortality worldwide. Recent estimates from the Global Burden of Disease studies indicate that depressive and anxiety disorders affect hundreds of millions of individuals globally and remain among the leading causes of years lived with disability[1,2]. Depression is a heterogeneous condition characterized by persistent low mood, anhedonia, cognitive impairment, and a range of somatic symptoms that vary across individuals and across the course of illness[3].
Sleep disturbance is one of the most common and clinically relevant features of depressive disorders. Disturbances in sleep continuity, quality, and timing are frequently reported by individuals with depression and are associated with greater symptom severity, functional impairment, and poorer prognosis[4,5]. Historically, sleep problems were conceptualized primarily as secondary symptoms of depression that would resolve with effective mood treatment. However, accumulating evidence has challenged this view, suggesting a more complex and bidirectional relationship between sleep disturbance and depressive psychopathology[6].
Prospective and longitudinal studies demonstrate that sleep disturbance often precedes the onset of depressive episodes and independently increases the risk of developing depression. Meta analytic evidence indicates that in
Importantly, the strength of evidence supporting each directional pathway is not uniform across populations. Prospective longitudinal studies, particularly in adolescents and young adults, more consistently demonstrate that insomnia and sleep disruption precede and predict the first onset of depressive episodes, supporting a potential contributory or causal role. In contrast, among older adults and individuals with significant medical comorbidity, the association is often more reciprocal and influenced by factors such as chronic illness, medication effects, and functional impairment. Recognizing these population specific nuances is essential to avoid overgeneralizing causality and to better interpret the clinical significance of sleep disturbance across the lifespan.
Neurobiological and physiological alterations in sleep architecture further support a close link between sleep regulation and mood. Depressive disorders are associated with characteristic changes in rapid eye movement sleep, including shortened latency and increased density, as well as disruptions in slow wave sleep and sleep continuity[9,11]. These alterations are thought to reflect dysregulation across interconnected neural systems involved in circadian timing, emotional processing, and stress responsivity[12,13].
Beyond neurophysiology, sleep disturbance may influence depression through multiple interacting pathways. Poor sleep quality has been associated with heightened emotional reactivity, impaired cognitive control, and reduced capacity for adaptive emotion regulation[14]. Sleep loss and fragmentation are also linked to activation of inflammatory pathways, which have been increasingly implicated in the pathophysiology of depression[15-17]. Experimental and translational studies further suggest that circadian rhythm disruption can alter reward processing, stress sensitivity, and mood regulation, providing a plausible mechanistic bridge between sleep disturbance and depressive symptoms[16].
Importantly, growing clinical evidence indicates that sleep disturbance is not merely an epiphenomenon of depression but represents a modifiable treatment target. Interventions that directly address sleep problems, particularly cognitive behavioral therapy for insomnia, have been shown to reduce depressive symptom severity and improve treatment outcomes, even when sleep is not the primary focus of intervention[18,19]. These findings underscore the need to re
Taken together, current evidence supports a reconceptualization of sleep disturbance as an active and integral component of depressive illness rather than a secondary or residual symptom. Understanding how sleep disturbance and depression interact across biological, psychological, and behavioral levels is essential for improving assessment, treatment, and prevention strategies.
This narrative review is based on a targeted and structured search of the literature. Relevant studies were identified through searches of PubMed, EMBASE, and Google Scholar up to March 2026 using combinations of keywords including “sleep disturbance”, “insomnia”, “circadian rhythm”, and “depression”. Priority was given to high-quality evidence, including meta-analyses, systematic reviews, longitudinal cohort studies, randomized controlled trials, and seminal mechanistic studies. Additional relevant articles were identified through reference lists of key publications. Given the narrative nature of this review, study selection was guided by relevance to the topic and conceptual contribution rather than formal inclusion and exclusion criteria.
In this narrative review, we synthesize current evidence on the bidirectional relationship between sleep disturbance and depression, with a focus on epidemiological findings, underlying biological and psychological mechanisms, clinical implications, and future research directions relevant to contemporary psychiatric practice.
Sleep disturbance in depression encompasses a heterogeneous group of symptoms that extend beyond difficulties with sleep duration alone. Contemporary conceptualizations emphasize sleep health as a multidimensional construct that includes sleep quality, continuity, timing, regularity, and daytime functioning[20]. In depressive disorders, disruption across one or more of these dimensions is common and clinically meaningful.
Insomnia is the most frequently reported sleep complaint in individuals with depression and is characterized by difficulty initiating sleep, difficulty maintaining sleep, or early morning awakening accompanied by daytime impairment. Population based studies demonstrate a robust association between insomnia symptoms and depressive symptom severity, even in individuals without a formal psychiatric diagnosis[21]. In clinical samples, insomnia has also been linked to increased suicide risk among individuals with depressive disorders, underscoring its clinical relevance beyond sleep related distress[22].
Insomnia in depression is often persistent rather than episodic and may continue despite improvement in mood symptoms. This persistence highlights the importance of assessing insomnia as a distinct clinical problem rather than assuming it will resolve with antidepressant treatment alone.
Hypersomnia represents a less prevalent but clinically important sleep phenotype in depressive disorders. It is characterized by prolonged nocturnal sleep duration, excessive daytime sleepiness, and difficulty awakening. Hypersomnia is particularly common in atypical depression and bipolar depression and may reflect dysregulation within circadian and homeostatic sleep systems[23,24].
Compared with insomnia, hypersomnia is less well studied and often underrecognized in routine clinical practice. Nevertheless, its presence may have implications for treatment selection and prognosis, particularly in mood disorders with prominent circadian rhythm involvement.
Disruption of circadian rhythm timing and stability is increasingly recognized as a core feature of depressive disorders. Delayed sleep phase, irregular sleep timing, and reduced circadian amplitude have been documented in individuals with unipolar depression, particularly among younger populations[25]. Such disruptions are associated with mood instability and may contribute to difficulties achieving sustained remission.
Circadian rhythm disturbance is distinct from insomnia or hypersomnia, although overlap frequently occurs. Identifying circadian misalignment requires attention to sleep timing and variability rather than sleep duration alone.
Accurate assessment of sleep disturbance in depression relies on both subjective and objective measures. Self report instruments such as the Pittsburgh Sleep Quality Index and the Insomnia Severity Index are widely used in both research and clinical settings and provide standardized evaluation of sleep quality and insomnia severity[26,27]. These tools are practical for routine screening and longitudinal monitoring.
Objective measures, including actigraphy, offer additional insights into sleep timing, fragmentation, and circadian patterns in naturalistic settings[28]. Although not routinely required in clinical practice, objective assessment may be valuable in complex cases or research contexts.
Sleep disturbance in depression varies across clinical contexts and populations. In bipolar disorder, sleep disruption is closely linked to mood instability and may precede both depressive and manic episodes[29,30]. Adolescents with depressive symptoms often exhibit delayed sleep timing and irregular sleep schedules, reflecting developmental and social influences on circadian regulation[31]. Occupational stress and irregular work schedules also contribute to sleep disturbance and depressive symptoms, particularly among healthcare workers and other high stress professions[32].
Fundamental principles of sleep wake regulation, including interactions between homeostatic sleep drive and circadian timing, provide a useful framework for understanding these diverse phenotypes[33]. Longitudinal evidence further indicates that persistent sleep disturbance, regardless of specific phenotype, increases the risk of subsequent depressive episodes[34,35].
The major phenotypes of sleep disturbance observed in depressive disorders, along with their clinical features and implications, are summarized in Table 1.
| Sleep disturbance phenotype | Core clinical features | Common depressive context | Key clinical implications |
| Insomnia | Difficulty initiating sleep, frequent nocturnal awakenings, early morning awakening with daytime impairment | Major depressive disorder, recurrent depression | Associated with greater symptom severity, poorer treatment response, and increased risk of relapse |
| Hypersomnia | Prolonged sleep duration, excessive daytime sleepiness, difficulty awakening | Atypical depression, bipolar depression | Suggests circadian and reward system involvement and may inform treatment selection |
| Circadian rhythm disruption | Delayed or irregular sleep timing, reduced circadian amplitude, increased variability in sleep timing | Unipolar and bipolar depression, shift work related depression | Associated with mood instability and poorer antidepressant response; potential target for chronotherapeutic interventions |
| Poor sleep quality | Nonrestorative sleep, sleep fragmentation, daytime dysfunction | Across depressive disorders | Linked to persistence of depressive symptoms and functional impairment independent of sleep duration |
Multiple interacting biological, psychological, and behavioral mechanisms link sleep disturbance with depressive disorders. Rather than operating through a single pathway, sleep disturbance appears to influence mood regulation through converging processes that affect emotional reactivity, stress sensitivity, cognitive functioning, and neural plasticity.
Sleep disturbance has been increasingly recognized as a core feature of depression rather than a secondary or nonspecific symptom. Conceptual and clinical work suggests that sleep disorders are tightly integrated into the phenomenology of depression and may reflect shared underlying pathophysiology[36]. Longitudinal studies further indicate that subjective sleep disturbance can precede the recurrence of depressive episodes, supporting its role as an early marker of vulnerability[37].
Taken together, these neurobiological alterations illustrate a reciprocal cycle: Sleep disturbance may initiate or amplify neurobiological vulnerabilities associated with depression, while depressive pathology further disrupts sleep regulatory systems, reinforcing and perpetuating both conditions.
Sleep plays a central role in emotional regulation. Insufficient or disrupted sleep is associated with heightened emotional reactivity and reduced capacity to regulate negative affect. Integrative models highlight that sleep loss impairs top down cognitive control over emotional responses, increasing vulnerability to mood dysregulation[38]. Experimental and observational studies also demonstrate that sleep disturbance amplifies physiological and psychological responses to stress, thereby increasing susceptibility to depressive symptoms[39].
Chronic stress exposure further compounds these effects. Prolonged activation of stress response systems can disrupt sleep continuity and circadian stability, while ongoing sleep disturbance reduces resilience to subsequent stressors. This reciprocal interaction between sleep and stress creates a feedback loop that promotes depressive vulnerability[40].
Thus, impaired sleep not only heightens emotional reactivity and negative cognitive bias, increasing vulnerability to depressive symptoms, but depressive rumination and affective dysregulation also worsen sleep quality, sustaining a self reinforcing cycle.
Circadian rhythm disruption represents a key biological pathway linking sleep disturbance to depression. Alterations in circadian timing and amplitude influence multiple neurobiological systems involved in mood regulation, including monoaminergic signaling, reward processing, and neuroplasticity[41]. Disruption of these rhythms may therefore contribute to both the onset and persistence of depressive symptoms.
Neurobiological studies further suggest that sleep loss and circadian misalignment affect inflammatory signaling and immune function. Meta analytic evidence indicates elevated proinflammatory cytokines in individuals with major depression, a process that may be exacerbated by chronic sleep disturbance[42]. Inflammatory activation has been proposed as a mechanism through which sleep disruption contributes to depressive symptomatology.
In this way, sleep disturbance may sensitize stress response systems and contribute to the development of depression, whereas chronic depressive stress further destabilizes sleep architecture, strengthening the bidirectional relationship.
Cognitive processes provide an additional link between sleep disturbance and depression. Poor sleep is associated with increased rumination, negative cognitive bias, and impaired executive functioning, all of which are central features of depressive disorders[43]. Rumination in particular has been shown to predict subsequent sleep disturbance, suggesting a bidirectional relationship between cognitive style and sleep problems[44].
Behavioral consequences of sleep deprivation further contribute to mood dysregulation. Experimental studies demonstrate that sleep loss amplifies reactivity within neural reward networks, potentially altering motivation and reward sensitivity in ways that resemble depressive phenotypes[45]. Disrupted sleep architecture, including alterations in slow wave sleep, may also impair overnight memory consolidation and emotional processing, reinforcing negative cognitive and affective patterns[46].
Circadian misalignment can therefore function as both a precipitating factor for depressive symptoms and a consequence of mood dysregulation, creating a dynamic feedback loop between biological rhythms and affective state.
Integrative models propose that circadian disruption, emotional dysregulation, stress sensitivity, and cognitive vulnerability interact dynamically over time to link sleep disturbance with depression. Circadian rhythms influence mood through effects on neurotransmission and neural plasticity, while mood states reciprocally shape sleep timing and quality[47]. At the clinical level, sleep disturbance is highly prevalent across psychiatric disorders, underscoring its transdiagnostic relevance[48].
Together, these mechanisms support the view that sleep disturbance is both a contributor to and a consequence of depressive psychopathology. Understanding these interconnected pathways provides a foundation for developing targeted interventions that address sleep and mood simultaneously.
Sleep loss may promote inflammatory activation that contributes to depressive symptomatology, while depression associated inflammatory processes can further impair sleep continuity, illustrating another biologically plausible bidirectional pathway.
While sleep disturbance can contribute to the development and persistence of depressive disorders, depression itself exerts profound effects on sleep regulation. Depressive psychopathology alters sleep architecture, circadian timing, and sleep related behaviors, leading to persistent and often treatment resistant sleep disturbance.
Depressive disorders are associated with characteristic alterations in sleep architecture. Clinical and neurophysiological studies have consistently demonstrated changes in rapid eye movement sleep, including shortened REM latency and increased REM density, as well as reductions in slow wave sleep[49]. These alterations are thought to reflect dysregulation within neural circuits involved in affective processing and arousal regulation.
Changes in sleep architecture may have functional consequences for emotional memory processing. Experimental evidence suggests that disruption of slow wave sleep impairs overnight consolidation of emotional memories, potentially reinforcing negative cognitive and affective biases in depression[50]. Such alterations may contribute to the persistence of depressive symptoms even when daytime mood appears to improve.
Depression is also associated with disruptions in circadian rhythm timing. Delayed sleep phase, irregular sleep schedules, and increased variability in sleep timing have been documented in individuals with depressive disorders, particularly among younger adults[51]. Circadian misalignment may exacerbate mood symptoms by disrupting the synchronization of biological rhythms with environmental and social cues.
Circadian phase shifts may interact with underlying vulnerability factors, including genetic predisposition and environmental stress, to sustain depressive symptoms. These disruptions can persist across depressive episodes and may represent a trait like vulnerability in some individuals.
Behavioral changes associated with depression further disrupt sleep. Reduced daytime activity, increased time spent in bed, irregular sleep schedules, and excessive napping are common in depressive states and can weaken homeostatic sleep drive[52]. These behaviors, although often adopted in response to fatigue or low motivation, may paradoxically worsen insomnia and sleep fragmentation.
Cognitive factors also play a role. Negative expectations about sleep, heightened preoccupation with sleep difficulties, and maladaptive coping strategies can increase cognitive and physiological arousal at night. Over time, these processes may condition persistent sleep disturbance independent of current mood state[53].
Importantly, sleep disturbance frequently persists even after depressive symptoms improve. Clinical studies indicate that residual insomnia is common following remission and is associated with increased risk of relapse[54]. Persistent sleep problems may therefore represent a critical target for relapse prevention.
Pharmacological treatment of depression can also influence sleep patterns. Although some antidepressants improve sleep continuity, others may exacerbate sleep fragmentation or alter sleep architecture, contributing to ongoing sleep complaints[49]. These observations highlight the need for careful monitoring of sleep throughout the course of depression treatment.
Across diagnostic categories and developmental stages, sleep disturbance manifests in distinct but clinically mea
Increasing evidence supports a bidirectional and self reinforcing relationship between sleep disturbance and depressive disorders. Rather than representing a simple cause and effect association, sleep disturbance and depression appear to interact dynamically over time, with each influencing the onset, severity, and persistence of the other.
Contemporary models conceptualize sleep disturbance as both a risk factor for and a consequence of depression. Digital and behavioral intervention studies provide indirect support for this framework by demonstrating that targeted treatment of sleep disturbance can lead to meaningful improvements in depressive symptoms, even when mood is not the primary treatment focus[55]. These findings suggest that sleep disturbance plays an active role in maintaining depressive psychopathology.
Chronotherapeutic approaches further illustrate the bidirectional relationship between sleep and mood. Interventions that modify sleep timing and circadian alignment have been shown to influence depressive symptoms, highlighting the sensitivity of mood regulation to changes in sleep wake timing[56].
Sleep disturbance and depression are linked through multiple feedback loops that reinforce symptom persistence. Disrupted sleep impairs emotional regulation, increases fatigue, and reduces motivation, which may exacerbate depressive symptoms. In turn, depressive behaviors such as reduced daytime activity, irregular routines, and social withdrawal further destabilize sleep patterns.
Technological advances have enabled more detailed examination of these feedback processes. Objective sleep monitoring using actigraphy and wearable devices reveals that increased night to night variability in sleep timing and duration is associated with mood instability, supporting the presence of ongoing reciprocal interactions between sleep and affect[57].
The bidirectional cycle between sleep disturbance and depression has important implications for long term illness course. Longitudinal evidence indicates that persistent sleep disturbance increases vulnerability to a range of mental disorders, including depression, even after controlling for baseline symptom severity[58]. Residual sleep disturbance following remission may therefore represent a key mechanism underlying relapse.
Sleep disturbance also interacts with individual vulnerability factors, such as stress sensitivity and circadian predisposition, to shape illness trajectories. These interactions may explain why some individuals experience recurrent depressive episodes despite adequate treatment of mood symptoms.
Recognizing the bidirectional relationship between sleep disturbance and depression shifts the clinical focus from symptom hierarchy to dynamic interaction. Viewing sleep disturbance as an integral component of depressive illness supports integrated treatment approaches that address both sleep and mood simultaneously rather than sequentially.
This framework also highlights the importance of early intervention. Addressing sleep disturbance during periods of subthreshold depressive symptoms or heightened stress may interrupt the progression toward full syndromal depression and reduce long term morbidity[59].
Viewing sleep disturbance and depression as dynamically interacting processes has important implications for clinical assessment, treatment planning, and long term management. Recognizing sleep disturbance as a core component of depressive illness rather than a secondary symptom supports more comprehensive and effective approaches to care.
The clinical relevance of sleep focused intervention may also vary across populations. In younger individuals, particularly adolescents and young adults where sleep disturbance frequently precedes depressive onset, early identification and treatment of insomnia or circadian misalignment may offer preventive potential. Conversely, in older adults and patients with chronic medical illness, sleep disturbance is often embedded within a broader network of comorbidity and functional decline, requiring integrated and multidisciplinary management rather than isolated sleep focused strategies alone. Appreciating these distinctions can support more realistic expectations of treatment response and more personalized care pathways.
Sleep disturbance should be systematically assessed in all individuals presenting with depressive symptoms, regardless of illness stage or severity. Evaluation should extend beyond sleep duration to include sleep quality, continuity, timing, and regularity. Persistent or severe sleep disturbance may indicate underlying neurobiological dysregulation that contributes to depressive vulnerability and warrants targeted intervention.
Advances in understanding the neurobiology of chronic insomnia highlight the importance of integrating sleep assessment into routine psychiatric evaluation. Contemporary models emphasize that insomnia involves alterations in arousal regulation and neural plasticity that may interact with mood symptoms over time[60]. Failure to identify and address these processes may limit treatment response and increase the risk of symptom persistence.
Clinical evidence supports the inclusion of sleep focused interventions as part of standard depression care. Treating sleep disturbance may improve depressive symptoms, enhance response to antidepressant therapies, and reduce the likelihood of relapse. Importantly, sleep disturbance often persists after apparent mood remission and may serve as an early warning signal for recurrence.
Clinical practice guidelines increasingly recommend targeted treatment of insomnia in adults, including behavioral and cognitive interventions, as a core component of care rather than an adjunctive strategy[61]. Integrating these approaches into depression management may improve both short term outcomes and long term illness trajectories.
The clinical implications of the bidirectional relationship between sleep disturbance and depression are summarized in Table 2.
| Clinical domain | Sleep focused approach | Key therapeutic goal | Practical relevance for care |
| Acute symptom management | Cognitive behavioral therapy for insomnia | Improve sleep initiation, maintenance, and sleep quality | Reduces depressive symptom severity and improves daytime functioning without medication related adverse effects |
| Pharmacological support | Hypnotics, sedating antidepressants, and melatonin based agents | Short term stabilization of sleep patterns | May provide rapid symptom relief when insomnia is severe, with careful monitoring for dependence and side effects |
| Circadian rhythm realignment | Light therapy, sleep phase adjustment, and structured daily routines | Restore biological rhythm stability | Particularly beneficial in patients with delayed sleep phase, seasonal patterns, or bipolar related rhythm instability |
| Integrated sleep and mood treatment | Combined sleep and antidepressant interventions | Simultaneous targeting of sleep disturbance and mood symptoms | Enhances overall treatment response and may accelerate recovery |
| Prevention of depressive onset | Early identification and treatment of sleep disturbance | Reduce vulnerability to first depressive episode | Especially relevant in adolescents and high risk populations |
| Relapse prevention and maintenance | Ongoing monitoring and treatment of residual insomnia | Sustain remission and reduce recurrence risk | Persistent sleep problems are strong predictors of depressive relapse and warrant proactive follow up |
Several contextual and individual level factors may further shape the presentation of sleep disturbance in depression and influence treatment response. Gender related differences in sleep architecture, hormonal fluctuations, and insomnia prevalence may partially explain variation in symptom expression across the lifespan. Socioeconomic conditions such as shift work, housing instability, caregiving burden, and chronic stress exposure can limit sleep opportunity and complicate behavioral interventions. Cultural norms surrounding sleep practices, symptom reporting, and help seeking behavior may also affect both recognition and management of sleep problems. Incorporating these modulating factors into clinical assessment may enhance personalization of sleep focused and mood focused interventions.
Despite substantial advances in understanding the relationship between sleep disturbance and depression, important gaps remain. Addressing these gaps will be essential for translating current knowledge into more effective, timely, and personalized approaches to prevention and treatment.
Future research should prioritize longitudinal designs that clarify temporal and causal pathways between sleep disturbance and depression across different stages of illness. Although existing evidence supports bidirectionality, many studies rely on self reported sleep measures and relatively short follow up periods. Long term cohort studies incor
Interventional research should further evaluate sleep focused treatments as primary or early interventions rather than adjunctive strategies. While current evidence supports the antidepressant effects of treating insomnia, additional randomized trials are needed to determine optimal timing, sequencing, and combinations of sleep and mood inter
Beyond evaluating clinical efficacy, future studies should prioritize mechanistic intervention research to clarify how improvements in sleep translate into mood stabilization. Investigations examining pathways such as emotional regulation, cognitive reactivity, circadian alignment, stress system normalization, and inflammatory modulation would help identify the specific processes through which sleep focused therapies exert antidepressant effects. Such mechanistic insight may enable more targeted and personalized intervention strategies across depressive subtypes.
Advances in neuroimaging, genetics, and immunology offer opportunities to refine mechanistic understanding of the sleep depression interface. Biomarkers related to circadian rhythm stability, stress reactivity, and immune activation may help identify individuals at elevated risk and predict treatment response. Integrating biological markers with clinical phenotyping could improve precision in both prevention and intervention strategies.
Emerging work on circadian gene expression and epigenetic regulation may further clarify individual differences in vulnerability to sleep related mood disturbance. Such approaches may help explain why sleep disruption precipitates depression in some individuals while others remain relatively resilient.
Digital technologies provide new opportunities for continuous and objective monitoring of sleep in naturalistic settings. Wearable devices and smartphone based assessments can capture sleep timing, variability, and fragmentation over extended periods, offering insights that are not easily obtained through traditional clinic based assessments. When combined with longitudinal mood monitoring, these tools may facilitate early detection of deterioration and support timely intervention.
Future research must also address challenges related to data validity, privacy, and clinical integration. Establishing standardized frameworks for interpreting and acting on digital sleep data will be essential before widespread adoption in routine psychiatric care.
Additional considerations include unequal access to digital technologies across socioeconomic groups, variability in device accuracy in clinical populations, and concerns related to data ownership and long term privacy. Moreover, frequent self monitoring may increase health related anxiety or symptom preoccupation in some individuals. Addressing these issues through validation studies, ethical frameworks, and patient centered implementation strategies will be critical for the responsible integration of digital sleep monitoring into mental health care.
Although sleep disturbance is widely recognized as relevant to depression, it remains under emphasized in many clinical guidelines. Future guideline development should more explicitly incorporate sleep assessment and intervention as core components of depression management. Clear recommendations regarding screening, referral pathways, and stepped care models that integrate sleep focused treatments across primary and specialty mental health settings are needed.
In parallel, clinician education and health system level implementation strategies will be essential to ensure that advances in sleep research translate into routine clinical practice. Embedding sleep focused approaches within collaborative and preventive care models may help reduce the long term burden of depressive disorders.
In conclusion, accumulating evidence supports a dynamic and bidirectional relationship between sleep disturbance and depression, in which each condition can precipitate, exacerbate, and sustain the other through interconnected biological, psychological, and circadian mechanisms. Recognizing sleep disturbance as both a risk factor and a core component of depressive illness has important implications for prevention, early intervention, and long term management.
Effective clinical application requires a personalized approach that considers key modulating elements, including predominant sleep phenotype (such as insomnia, hypersomnia, or circadian misalignment), age and developmental stage, comorbid psychiatric and medical conditions, psychosocial context, and individual treatment responsiveness. Integrating routine sleep assessment with targeted sleep focused interventions alongside standard mood treatments may enhance therapeutic outcomes and reduce relapse risk. Continued mechanistic research and implementation efforts will be essential to translate growing scientific insight into sustainable improvements in depression care.
The authors thank their colleagues for helpful discussions during the preparation of this manuscript.
| 1. | COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700-1712. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4239] [Cited by in RCA: 3298] [Article Influence: 659.6] [Reference Citation Analysis (1)] |
| 2. | GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137-150. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5012] [Cited by in RCA: 4036] [Article Influence: 1009.0] [Reference Citation Analysis (1)] |
| 3. | Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299-2312. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3532] [Cited by in RCA: 3078] [Article Influence: 384.8] [Reference Citation Analysis (0)] |
| 4. | Plante DT. The Evolving Nexus of Sleep and Depression. Am J Psychiatry. 2021;178:896-902. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 113] [Cited by in RCA: 93] [Article Influence: 18.6] [Reference Citation Analysis (0)] |
| 5. | Joo HJ, Kwon KA, Shin J, Park S, Jang SI. Association between sleep quality and depressive symptoms. J Affect Disord. 2022;310:258-265. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 46] [Article Influence: 11.5] [Reference Citation Analysis (0)] |
| 6. | Mirchandaney R, Asarnow LD, Kaplan KA. Recent advances in sleep and depression. Curr Opin Psychiatry. 2023;36:34-40. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 46] [Reference Citation Analysis (0)] |
| 7. | Hertenstein E, Trinca E, Wunderlin M, Schneider CL, Züst MA, Fehér KD, Su T, Straten AV, Berger T, Baglioni C, Johann A, Spiegelhalder K, Riemann D, Feige B, Nissen C. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2022;62:101597. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 325] [Cited by in RCA: 254] [Article Influence: 63.5] [Reference Citation Analysis (0)] |
| 8. | Pigeon WR, Hegel M, Unützer J, Fan MY, Sateia MJ, Lyness JM, Phillips C, Perlis ML. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31:481-488. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 235] [Cited by in RCA: 220] [Article Influence: 12.2] [Reference Citation Analysis (0)] |
| 9. | Palagini L, Baglioni C, Ciapparelli A, Gemignani A, Riemann D. REM sleep dysregulation in depression: state of the art. Sleep Med Rev. 2013;17:377-390. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 239] [Cited by in RCA: 352] [Article Influence: 27.1] [Reference Citation Analysis (0)] |
| 10. | Gao T, Xiang H, Wu QN, Zhu LS, Pei WJ, Fu WJ, Chou TS. Advances in the research of comorbid insomnia and depression: mechanisms, impacts, and interventions. Front Psychiatry. 2025;16:1468212. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 10] [Reference Citation Analysis (0)] |
| 11. | Riemann D, Krone LB, Wulff K, Nissen C. Sleep, insomnia, and depression. Neuropsychopharmacology. 2020;45:74-89. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 711] [Cited by in RCA: 567] [Article Influence: 94.5] [Reference Citation Analysis (0)] |
| 12. | Foster RG, Wulff K. The rhythm of rest and excess. Nat Rev Neurosci. 2005;6:407-414. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 164] [Cited by in RCA: 169] [Article Influence: 8.0] [Reference Citation Analysis (0)] |
| 13. | Lyall LM, Wyse CA, Graham N, Ferguson A, Lyall DM, Cullen B, Celis Morales CA, Biello SM, Mackay D, Ward J, Strawbridge RJ, Gill JMR, Bailey MES, Pell JP, Smith DJ. Association of disrupted circadian rhythmicity with mood disorders, subjective wellbeing, and cognitive function: a cross-sectional study of 91 105 participants from the UK Biobank. Lancet Psychiatry. 2018;5:507-514. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 355] [Cited by in RCA: 284] [Article Influence: 35.5] [Reference Citation Analysis (0)] |
| 14. | Pandi-Perumal SR, Monti JM, Burman D, Karthikeyan R, BaHammam AS, Spence DW, Brown GM, Narashimhan M. Clarifying the role of sleep in depression: A narrative review. Psychiatry Res. 2020;291:113239. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 295] [Cited by in RCA: 246] [Article Influence: 41.0] [Reference Citation Analysis (0)] |
| 15. | Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19:702-715. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 190] [Cited by in RCA: 718] [Article Influence: 119.7] [Reference Citation Analysis (2)] |
| 16. | Walker WH 2nd, Walton JC, DeVries AC, Nelson RJ. Circadian rhythm disruption and mental health. Transl Psychiatry. 2020;10:28. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 831] [Cited by in RCA: 642] [Article Influence: 107.0] [Reference Citation Analysis (1)] |
| 17. | Bower JE, Kuhlman KR. Psychoneuroimmunology: An Introduction to Immune-to-Brain Communication and Its Implications for Clinical Psychology. Annu Rev Clin Psychol. 2023;19:331-359. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 89] [Cited by in RCA: 80] [Article Influence: 26.7] [Reference Citation Analysis (0)] |
| 18. | Scott AJ, Webb TL, Martyn-St James M, Rowse G, Weich S. Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials. Sleep Med Rev. 2021;60:101556. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 858] [Cited by in RCA: 657] [Article Influence: 131.4] [Reference Citation Analysis (1)] |
| 19. | Furukawa Y, Sakata M, Yamamoto R, Nakajima S, Kikuchi S, Inoue M, Ito M, Noma H, Takashina HN, Funada S, Ostinelli EG, Furukawa TA, Efthimiou O, Perlis M. Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-Analysis. JAMA Psychiatry. 2024;81:357-365. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 124] [Cited by in RCA: 109] [Article Influence: 54.5] [Reference Citation Analysis (1)] |
| 20. | St-Onge MP, Aggarwal B, Fernandez-Mendoza J, Johnson D, Kline CE, Knutson KL, Redeker N, Grandner MA; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Multidimensional Sleep Health: Definitions and Implications for Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2025;18:e000139. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 56] [Cited by in RCA: 55] [Article Influence: 55.0] [Reference Citation Analysis (0)] |
| 21. | Hertenstein E, Feige B, Gmeiner T, Kienzler C, Spiegelhalder K, Johann A, Jansson-Fröjmark M, Palagini L, Rücker G, Riemann D, Baglioni C. Insomnia as a predictor of mental disorders: A systematic review and meta-analysis. Sleep Med Rev. 2019;43:96-105. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 352] [Cited by in RCA: 840] [Article Influence: 105.0] [Reference Citation Analysis (4)] |
| 22. | Nadorff MR, Nazem S, Fiske A. Insomnia symptoms, nightmares, and suicide risk: duration of sleep disturbance matters. Suicide Life Threat Behav. 2013;43:139-149. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 90] [Cited by in RCA: 108] [Article Influence: 8.3] [Reference Citation Analysis (0)] |
| 23. | Trotti LM, Arnulf I. Idiopathic Hypersomnia and Other Hypersomnia Syndromes. Neurotherapeutics. 2021;18:20-31. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 17] [Cited by in RCA: 35] [Article Influence: 7.0] [Reference Citation Analysis (0)] |
| 24. | Kaplan KA, Harvey AG. Hypersomnia across mood disorders: a review and synthesis. Sleep Med Rev. 2009;13:275-285. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 147] [Cited by in RCA: 154] [Article Influence: 9.1] [Reference Citation Analysis (0)] |
| 25. | Logan RW, McClung CA. Rhythms of life: circadian disruption and brain disorders across the lifespan. Nat Rev Neurosci. 2019;20:49-65. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 297] [Cited by in RCA: 501] [Article Influence: 71.6] [Reference Citation Analysis (0)] |
| 26. | Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 27831] [Cited by in RCA: 24101] [Article Influence: 651.4] [Reference Citation Analysis (8)] |
| 27. | Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297-307. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 6712] [Cited by in RCA: 5862] [Article Influence: 234.5] [Reference Citation Analysis (1)] |
| 28. | Ancoli-Israel S, Martin JL, Blackwell T, Buenaver L, Liu L, Meltzer LJ, Sadeh A, Spira AP, Taylor DJ. The SBSM Guide to Actigraphy Monitoring: Clinical and Research Applications. Behav Sleep Med. 2015;13 Suppl 1:S4-S38. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 294] [Cited by in RCA: 408] [Article Influence: 37.1] [Reference Citation Analysis (0)] |
| 29. | Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165:820-829. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 489] [Cited by in RCA: 412] [Article Influence: 22.9] [Reference Citation Analysis (0)] |
| 30. | Geoffroy PA, Scott J, Boudebesse C, Lajnef M, Henry C, Leboyer M, Bellivier F, Etain B. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand. 2015;131:89-99. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 143] [Cited by in RCA: 186] [Article Influence: 16.9] [Reference Citation Analysis (0)] |
| 31. | Crowley SJ, Wolfson AR, Tarokh L, Carskadon MA. An update on adolescent sleep: New evidence informing the perfect storm model. J Adolesc. 2018;67:55-65. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 524] [Cited by in RCA: 468] [Article Influence: 58.5] [Reference Citation Analysis (0)] |
| 32. | Coelho J, Lucas G, Micoulaud-Franchi JA, Philip P, Boyer L, Fond G. Poor sleep is associated with work environment among 10,087 French healthcare workers: Results from a nationwide survey. Psychiatry Res. 2023;328:115448. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 14] [Cited by in RCA: 8] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
| 33. | Dijk DJ, Lockley SW. Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol (1985). 2002;92:852-862. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 266] [Cited by in RCA: 213] [Article Influence: 8.9] [Reference Citation Analysis (0)] |
| 34. | Jia T, Kou C, Zhang Y, Sun Z, Ding Q, Feng Y, Guo X, Wu S, Wang Q, Huang Q, Sun X, Han W, Bai W. Associations Between Sleep Duration Trajectories and Depressive Symptoms Among Middle-Aged and Older Adults: Findings From a Nationally Representative Survey. Int J Geriatr Psychiatry. 2025;40:e70154. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 2] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
| 35. | Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10-19. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2264] [Cited by in RCA: 1871] [Article Influence: 124.7] [Reference Citation Analysis (3)] |
| 36. | Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10:329-336. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 353] [Cited by in RCA: 542] [Article Influence: 30.1] [Reference Citation Analysis (0)] |
| 37. | Freeman D, Sheaves B, Waite F, Harvey AG, Harrison PJ. Sleep disturbance and psychiatric disorders. Lancet Psychiatry. 2020;7:628-637. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 162] [Cited by in RCA: 518] [Article Influence: 86.3] [Reference Citation Analysis (0)] |
| 38. | Palmer CA, Alfano CA. Sleep and emotion regulation: An organizing, integrative review. Sleep Med Rev. 2017;31:6-16. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 313] [Cited by in RCA: 584] [Article Influence: 64.9] [Reference Citation Analysis (0)] |
| 39. | Vargas I, Lopez-Duran N. Investigating the effect of acute sleep deprivation on hypothalamic-pituitary-adrenal-axis response to a psychosocial stressor. Psychoneuroendocrinology. 2017;79:1-8. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 32] [Cited by in RCA: 44] [Article Influence: 4.9] [Reference Citation Analysis (0)] |
| 40. | McEwen BS. Neurobiological and Systemic Effects of Chronic Stress. Chronic Stress (Thousand Oaks). 2017;11:2470547017692328. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 264] [Cited by in RCA: 577] [Article Influence: 64.1] [Reference Citation Analysis (4)] |
| 41. | Cermakian N, Boivin DB. The regulation of central and peripheral circadian clocks in humans. Obes Rev. 2009;10 Suppl 2:25-36. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 70] [Cited by in RCA: 76] [Article Influence: 4.5] [Reference Citation Analysis (0)] |
| 42. | Bai Y, Cai Y, Chang D, Li D, Huo X, Zhu T. Immunotherapy for depression: Recent insights and future targets. Pharmacol Ther. 2024;257:108624. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 45] [Cited by in RCA: 45] [Article Influence: 22.5] [Reference Citation Analysis (0)] |
| 43. | O'Leary K, Bylsma LM, Rottenberg J. Why might poor sleep quality lead to depression? A role for emotion regulation. Cogn Emot. 2017;31:1698-1706. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 82] [Cited by in RCA: 107] [Article Influence: 11.9] [Reference Citation Analysis (0)] |
| 44. | Zoccola PM, Dickerson SS, Lam S. Rumination predicts longer sleep onset latency after an acute psychosocial stressor. Psychosom Med. 2009;71:771-775. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 136] [Cited by in RCA: 139] [Article Influence: 8.2] [Reference Citation Analysis (0)] |
| 45. | Gujar N, Yoo SS, Hu P, Walker MP. Sleep deprivation amplifies reactivity of brain reward networks, biasing the appraisal of positive emotional experiences. J Neurosci. 2011;31:4466-4474. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 400] [Cited by in RCA: 332] [Article Influence: 22.1] [Reference Citation Analysis (0)] |
| 46. | Wassing R, Benjamins JS, Talamini LM, Schalkwijk F, Van Someren EJW. Overnight worsening of emotional distress indicates maladaptive sleep in insomnia. Sleep. 2019;42:zsy268. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 64] [Cited by in RCA: 56] [Article Influence: 8.0] [Reference Citation Analysis (0)] |
| 47. | McClung CA. How might circadian rhythms control mood? Let me count the ways. Biol Psychiatry. 2013;74:242-249. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 321] [Cited by in RCA: 371] [Article Influence: 28.5] [Reference Citation Analysis (0)] |
| 48. | Harvey AG. A transdiagnostic approach to treating sleep disturbance in psychiatric disorders. Cogn Behav Ther. 2009;38 Suppl 1:35-42. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 56] [Cited by in RCA: 77] [Article Influence: 5.5] [Reference Citation Analysis (0)] |
| 49. | Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of Antidepressants on Sleep. Curr Psychiatry Rep. 2017;19:63. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 413] [Cited by in RCA: 347] [Article Influence: 38.6] [Reference Citation Analysis (0)] |
| 50. | Riemann D, Benz F, Dressle RJ, Espie CA, Johann AF, Blanken TF, Leerssen J, Wassing R, Henry AL, Kyle SD, Spiegelhalder K, Van Someren EJW. Insomnia disorder: State of the science and challenges for the future. J Sleep Res. 2022;31:e13604. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 216] [Article Influence: 54.0] [Reference Citation Analysis (0)] |
| 51. | Zhang D, Qu Y, Zhai S, Li T, Xie Y, Tao S, Zou L, Tao F, Wu X. Association between healthy sleep patterns and depressive trajectories among college students: a prospective cohort study. BMC Psychiatry. 2023;23:182. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 8] [Reference Citation Analysis (0)] |
| 52. | Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40:869-893. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 963] [Cited by in RCA: 1131] [Article Influence: 47.1] [Reference Citation Analysis (0)] |
| 53. | Tellenbach N, Schmidt MH, Alexiev F, Blondiaux E, Cavalloni F, Bassetti CL, Heydrich L, Bargiotas P. REM sleep and muscle atonia in brainstem stroke: A quantitative polysomnographic and lesion analysis study. J Sleep Res. 2023;32:e13640. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 5] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
| 54. | Rumble ME, White KH, Benca RM. Sleep Disturbances in Mood Disorders. Psychiatr Clin North Am. 2015;38:743-759. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 80] [Cited by in RCA: 87] [Article Influence: 7.9] [Reference Citation Analysis (0)] |
| 55. | Cheng P, Luik AI, Fellman-Couture C, Peterson E, Joseph CLM, Tallent G, Tran KM, Ahmedani BK, Roehrs T, Roth T, Drake CL. Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial. Psychol Med. 2019;49:491-500. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 152] [Cited by in RCA: 134] [Article Influence: 19.1] [Reference Citation Analysis (0)] |
| 56. | Wirz-Justice A, Benedetti F. Perspectives in affective disorders: Clocks and sleep. Eur J Neurosci. 2020;51:346-365. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 82] [Cited by in RCA: 72] [Article Influence: 12.0] [Reference Citation Analysis (0)] |
| 57. | Scott H, Lack L, Lovato N. A systematic review of the accuracy of sleep wearable devices for estimating sleep onset. Sleep Med Rev. 2020;49:101227. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 50] [Cited by in RCA: 98] [Article Influence: 14.0] [Reference Citation Analysis (0)] |
| 58. | Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry. 2008;165:1543-1550. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 221] [Cited by in RCA: 212] [Article Influence: 11.8] [Reference Citation Analysis (0)] |
| 59. | Corrections. Lancet Psychiatry. 2016;3:320. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 60. | Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015;14:547-558. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 276] [Cited by in RCA: 424] [Article Influence: 38.5] [Reference Citation Analysis (0)] |
| 61. | Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165:125-133. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1621] [Cited by in RCA: 1321] [Article Influence: 132.1] [Reference Citation Analysis (0)] |